Krystal Biotech, Inc.
Krystal Biotech, Inc.
Explore linked clinical trials.11 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Investigate Safety and Efficacy of KB111 for the Treatment of Hailey-Hailey Disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hailey-Hailey disease, Skin and Connective Tissue Diseases, hereditary disease, hereditary skin disorder, skin disorder, vesiculobullous skin disease | Recruiting | Early phase 1 | 2026-07-21 | NCT07717346 | |
| A Study Assessing KB407 for the Treatment of Cystic Fibrosis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Infant, Newborn, Diseases, cystic fibrosis, hereditary disease, lung disorder, pancreas disorder, respiratory system disorder | Recruiting | Phase 1 | 2026-05-07 | NCT05504837 | |
| A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa | Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Corneal Injuries, Craniocerebral Trauma, Eye Injuries, Facial Injuries, Skin Abnormalities, Skin and Connective Tissue Diseases, connective tissue disorder, corneal disorder, epidermolysis bullosa, epidermolysis bullosa dystrophica, eye disorder, hereditary disease, hereditary skin disorder, injury, nervous system disorder, nervous system injury, recessive dystrophic epidermolysis bullosa, skin disorder, vesiculobullous skin disease | Recruiting | Phase 3 | 2026-03-12 | NCT07016750 | |
| A Study Comparing KB801 Verse Placebo in Patients With Stage 2 or 3 Neurotrophic Keratitis | neurotrophic keratopathy | Recruiting | Phase 1 / Phase 2 | 2026-02-27 | NCT06999733 | |
| A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 1 / Phase 2 | 2025-10-24 | NCT06228326 | |
| A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Subcutaneous Emphysema, alpha 1-antitrypsin deficiency, hereditary disease, liver disorder, lung disorder, pulmonary emphysema, respiratory system disorder | Recruiting | Phase 1 | 2025-07-22 | NCT06049082 | |
| A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB) | Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Corneal Injuries, Craniocerebral Trauma, Eye Injuries, Facial Injuries, Hallopeau-Siemens Disease, Skin Abnormalities, Skin and Connective Tissue Diseases, connective tissue disorder, corneal disorder, epidermolysis bullosa, epidermolysis bullosa dystrophica, eye disorder, hereditary disease, hereditary skin disorder, injury, nervous system disorder, nervous system injury, skin disorder, vesiculobullous skin disease | Recruiting | Not stated | 2025-07-02 | NCT06563414 | |
| A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, cancer, cutaneous melanoma, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Recruiting | Phase 1 / Phase 2 | 2025-05-18 | NCT05970497 | |
| A Study Assessing KB304 for the Treatment of Wrinkles in Women | Décolleté Wrinkles; Pigmentation; Wrinkles in Decolletage | Active, not recruiting | Phase 1 / Phase 2 | 2025-05-13 | NCT06724900 | |
| A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions | Fine Lines; Skin Roughness; Skin Thickness; Wrinkle | Active, not recruiting | Phase 1 | 2025-05-13 | NCT04540900 | |
| Long-Term Follow-up Protocol | Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Skin Abnormalities, Skin and Connective Tissue Diseases, connective tissue disorder, epidermolysis bullosa, epidermolysis bullosa dystrophica, hereditary disease, hereditary skin disorder, recessive dystrophic epidermolysis bullosa, skin disorder, vesiculobullous skin disease | Recruiting | Not stated | 2021-06-08 | NCT04917887 |